Even With Delay, Surgery Improves Survival in Early NSCLC Versus Stereotactic Radiation
Surgery was superior to stereotactic radiation for early non-small cell lung cancer, even in the...
Jan 27, 2023
Surgery was superior to stereotactic radiation for early non-small cell lung cancer, even in the...
Jan 20, 2023
The following is the summary of “Treatment Patterns and Outcomes in Resected Early-stage Non-small...
Jan 20, 2023
The following is the summary of “Treatment patterns and survival of patients with locoregional...
Jan 20, 2023
The following is the summary of “946P – Non-examination of lymph nodes (LN) in early-stage...
Jan 11, 2023
For patients with early-stage non-small cell lung cancer (eNSCLC), increased use of stereotactic...
Jan 3, 2023
The following is the summary of “Increased Utilization of Stereotactic Body Radiotherapy is...
Dec 30, 2022
The following is the summary of “Impact of TP53 Mutations on EGFR-Tyrosine Kinase Inhibitor...
Jun 14, 2022
The identification of circulating tumor DNA (ctDNA) following initial treatment among patients...
May 19, 2022
1. Patients who underwent segmentectomy reported a significantly greater 5-year overall survival...
Feb 25, 2022
While thoracoscopic sub-lobar resection (SR) appears to result in similar oncologic outcomes...
Feb 3, 2022
THURSDAY, Feb. 3, 2022 (HealthDay News) — A plasma assay that detects dysregulated lipids...
Jan 21, 2022
A research exhibited the contemporary approved approaches for the workup required to diagnose patients with early-stage non-small cell lung cancer (NSCLC) and their following treatment procedure. The researchers review the basis...